1.
Br J Urol
; 72(5 Pt 1): 668-9, 1993 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-10071568
2.
Br J Urol
; 64(6): 608-10, 1989 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-2627635
RESUMO
Poorly differentiated (G3) cancers are known to have a worse prognosis than other superficial bladder tumours. In the period 1976 to 1987, 53 patients with G3pT1 disease were treated by radical radiotherapy with a 5-year survival rate of 64%. Thirteen patients (25%) developed an invasive tumour during the follow-up period. The presence of secondary carcinoma in situ was associated with a poor prognosis. These results are better than those reported for transurethral resection alone and suggest that radiotherapy is the treatment of choice in G3 superficial tumours.